⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2113427 | 1.00 | — | — | |
| SCHEMBL16668883 | 0.96 | — | — | |
| SCHEMBL3662179 | 0.86 | FOLH1 (0.30) | — | |
| SCHEMBL2110937 | 0.86 | FOLH1 (0.30) | — | |
| SCHEMBL2110935 | 0.86 | FOLH1 (0.30) | — | |
| SCHEMBL16682592 | 0.82 | — | — | |
| SCHEMBL11165010 | 0.82 | — | — | |
| SCHEMBL8624298 | 0.78 | — | — | |
| SCHEMBL9632997 | 0.77 | DUT (0.33) | — | |
| SCHEMBL9117153 | 0.76 | CA2 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8455547-B2 | Substituted cyclopentanes having prostaglandin activity | ALLERGAN, INC. (US) | 2013-06-04 | — | — | US | disclosed |
| US-8158676-B2 | Substituted cyclopentanes having prostaglandin activity | ALLERGAN, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| US-8158676-B2 | Substituted cyclopentanes having prostaglandin activity | ALLERGAN, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| US-20090197962-A1 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY | ALLERGAN, INC. | 2009-08-06 | — | — | US | disclosed |
| US-20090143461-A1 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY | ALLERGAN, INC. | 2009-06-04 | — | — | US | disclosed |
| US-20090143461-A1 | SUBSTITUTED CYCLOPENTANES HAVING PROSTAGLANDIN ACTIVITY | ALLERGAN, INC. | 2009-06-04 | — | — | US | disclosed |